CS-2100

• CAT Number: I004302
• CAS Number: 913827-99-3
• Molecular Formula: C25H23N3O4S
• Molecular Weight: 461.53
• Purity: ≥95%
• Synonyms: 1-[[4-ethyl-5-[5-(4-phenoxyphenyl)-1,2,4-oxadiazol-3-yl]thiophen-2-yl]methyl]azetidine-3-carboxylic acid
• InChI: InChI=1S/C25H23N3O4S/c1-2-16-12-21(15-28-13-18(14-28)25(29)30)33-22(16)23-26-24(32-27-23)17-8-10-20(11-9-17)31-19-6-4-3-5-7-19/h3-12,18H,2,13-15H2,1H3,(H,29,30)
• InChIKey: DWVJASHDNJMDNH-UHFFFAOYSA-N
• SMILES: CCC1=C(SC(=C1)CN2CC(C2)C(=O)O)C3=NOC(=N3)C4=CC=C(C=C4)OC5=CC=CC=C5

CS-2100（Cat No.:I004302）is a novel small molecule inhibitor designed to target specific receptors involved in cancer cell signaling. It works by disrupting key pathways that contribute to tumor growth and survival. Preclinical studies have shown CS-2100 to exhibit potent antitumor activity, making it a promising candidate for cancer therapy, particularly in cancers that are resistant to existing treatments. Researchers are currently investigating its efficacy, pharmacokinetics, and safety in clinical trials to determine its potential as a therapeutic option for cancer patients. Further studies are necessary to establish its clinical benefits.